MELVILLE, N.Y.--(BUSINESS WIRE)--Canon U.S.A., Inc., a leader in digital imaging solutions, today announced that it has made a strategic investment in Spartan Bioscience Inc., a leader in on-demand DNA testing, to help fund the research and development of new diagnostic testing products. Canon BioMedical, Inc., the recently established wholly- owned subsidiary of Canon U.S.A., Inc., plans to explore areas to work with Spartan on the development of future diagnostic products, including rapid gen
| < Prev | Next > |
|---|
